Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-002224
Filing Date
2025-03-20
Accepted
2025-03-20 16:30:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4264
  Complete submission text file 0001959173-25-002224.txt   5680
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Farrow Jeffrey S (Reporting) CIK: 0001405253 (see all company filings)

Type: 144

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39614 | Film No.: 25756924
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)